15 Jahre Novartis
150 Jahre Innovation
| LEADER | cam a22 4500 | ||
|---|---|---|---|
| 001 | 279223129 | ||
| 003 | CHVBK | ||
| 005 | 20201008232807.0 | ||
| 008 | 130818s2011 sz a 01 0 ger d | ||
| 035 | |a (SNL)991016969579703976 | ||
| 035 | |a (SNL)991016990439703976 | ||
| 035 | |a (SNL)991016990409703976 | ||
| 035 | |a (IDSBB)005752219 | ||
| 035 | |a (IDSLU)001072242 | ||
| 035 | |a (SGBN)001143280 | ||
| 035 | |a (ABN)000698124 | ||
| 035 | |a (Sz)1669396-41snl_51 | ||
| 035 | |a (Sz)vtls001669396 | ||
| 035 | |a (Sz)001669396 | ||
| 035 | |a (Sz)1670114-41snl_51 | ||
| 035 | |a (Sz)vtls001670114 | ||
| 035 | |a (Sz)001670114 | ||
| 035 | |a (Sz)1670113-41snl_51 | ||
| 035 | |a (Sz)vtls001670113 | ||
| 035 | |a (Sz)001670113 | ||
| 035 | |a (GyWOH)har120094061 | ||
| 040 | |a Sz |c Sz | ||
| 082 | 0 | 4 | |a 338.76161510949432 |2 22/ger |
| 082 | 7 | 4 | |a 330 |2 23sdnb |
| 082 | 1 | |a 610 |2 15 | |
| 100 | 1 | |a Dettwiler |D Walter | |
| 245 | 1 | 0 | |a 15 Jahre Novartis |b 150 Jahre Innovation |c [Text: Walter Dettwiler] |
| 260 | |a Basel |b Novartis International |c cop. 2011 | ||
| 300 | |a 215 S. |b Ill. |c 28 cm | ||
| 500 | |a Register | ||
| 546 | |a Titel und Text in japan. Schrift und Sprache | ||
| 610 | 2 | 7 | |a CIBA-Geigy AG |0 (DE-588)2007014-7 |2 gnd |
| 610 | 2 | 7 | |a Novartis AG |0 (DE-588)2163228-5 |2 gnd |
| 610 | 2 | 7 | |a Sandoz AG |g Basel |0 (DE-588)9077-3 |2 gnd |
| 610 | 2 | 7 | |a J. R. Geigy AG |0 (DE-588)2016995-4 |2 gnd |
| 610 | 2 | 7 | |a CIBA-Geigy AG |0 (DE-588)4129656-4 |2 gnd |
| 610 | 2 | 7 | |a Novartis AG |0 (DE-588)4553029-4 |2 gnd |
| 610 | 2 | 7 | |a Sandoz AG |0 (DE-588)4051560-6 |2 gnd |
| 648 | 7 | |a Geschichte |2 gnd | |
| 648 | 7 | |a Geschichte 1996-2011 |2 gnd | |
| 648 | 7 | |a Geschichte 1859-2011 |2 gnd | |
| 650 | 7 | |a Chemische Industrie |0 (DE-588)4009848-5 |2 gnd | |
| 650 | 7 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |2 gnd | |
| 655 | 7 | |a Festschrift |2 gnd-content | |
| 690 | 7 | |B u |a Geigy |2 idsbb AC | |
| 690 | 7 | |B u |a Ciba-Geigy |2 idsbb AC | |
| 690 | 7 | |B u |a Sandoz |2 idsbb AC | |
| 690 | 7 | |B u |a Novartis |2 idsbb AC | |
| 691 | 7 | |a sb |b 2012/06 |c 330 |k bs |2 snl-sb | |
| 691 | 7 | |c 330 |2 snl-sb | |
| 691 | 7 | |B u |u 3.2.4.3.1 |2 idsbb FA | |
| 710 | 2 | |a Novartis AG |0 (DE-588)2163228-5 | |
| 730 | 0 | |a Festschrift |g Novartis | |
| 856 | 4 | 1 | |u https://opac.admin.ch/toc/toc001669396.pdf |y Inhaltsverzeichnis |
| 898 | |a BK020000 |b XK020000 |c XK020000 | ||
| 898 | |a BK020400 |b XK020000 |c XK020000 | ||
| 909 | 7 | |b basb11 |2 idsbb A | |
| 912 | 7 | |a wg |2 SzZuIDS BS/BE | |
| 912 | 7 | |a 0 |2 IDS LU | |
| 949 | |B SNL |F NB001 |b NB001 |j JB 338.7616151 DETT |c NB10023 | ||
| 949 | |B SNL |F NB001 |b NB001 |j Nq 173295 |c NB10010 | ||
| 949 | |B SNL |F NB001 |b NB001 |j Nq 173336 |c NB10010 | ||
| 949 | |B SNL |F NB001 |b NB001 |j Nq 173335 |c NB10010 | ||
| 949 | |B IDSBB |F A115 |b A115 |c 115BB |x Exemplarsatz per System ergänzt (Mai 2018) | ||
| 949 | |B IDSBB |F A348 |b A348 |c FH |j STA QuartCv 3088 |x NELA3481206 / Akz.:g/2012,021 | ||
| 949 | |B IDSBB |F A125 |b A125 |c 125ST |j SWA H + I Bf 212 (Bro) |x NELA1251204 | ||
| 949 | |B IDSBB |F B434 |b B434 |c 434MO |j StAB C 2292 |x nelb4341211 | ||
| 949 | |B IDSBB |F A298 |b A298 |c PR |j HM Bk qu 153 |x NELA2981201 HMBG2012 | ||
| 949 | |B IDSBB |F A304 |b A304 |c PR |j PHM Ac 172 |x NELA3041512 | ||
| 949 | |B IDSBB |F B513 |b B513 |c 513SF |j CM 658.1(09) |x NELB5131308 | ||
| 950 | |B SNL |P 856 |E 41 |u https://opac.admin.ch/toc/toc001669396.pdf |y Inhaltsverzeichnis | ||
| 950 | |B SNL |P 100 |E 1- |a Dettwiler |D Walter | ||
| 950 | |B SNL |P 710 |E 2- |a Novartis AG |0 (DE-588)2163228-5 | ||
| 950 | |B SNL |P 730 |E -- |a Festschrift |g Novartis | ||
| 950 | |B IDSBB |P 700 |E 1- |a Dettwiler |D Walter |d 1960- |0 (DE-588)122197267 | ||
| 950 | |B IDSBB |P 700 |E 1- |a Vasella |D Daniel |d 1953- |0 (DE-588)1041810482 | ||
| 950 | |B IDSBB |P 710 |E 2- |a Novartis AG |0 (DE-588)2163228-5 | ||
| 950 | |B IDSLU |P 100 |E 1- |a Dettwiler |D Walter | ||
| 950 | |B IDSLU |P 710 |E 2- |a Novartis AG |0 (DE-588)2163228-5 | ||
| 950 | |B SGBN |P 700 |E 1- |a Dettwiler |D Walter | ||
| 950 | |B SGBN |P 700 |E 1- |a Vasella |D Daniel | ||
| 950 | |B SGBN |P 710 |E 2- |a Novartis | ||
| 950 | |B ABN |P 700 |E 1- |a Dettwiler |D Walter | ||
| 956 | 4 | |B IDSBB |C DSV51 |D DSV01 |a A100 |u http://www.ub.unibas.ch/tox/IDSBB/005752219/PDF |q pdf |x VIEW |y Inhaltsverzeichnis | |